Resolution of ST elevation
Showing 1 - 25 of 7,738
MPV,PDW,PFT and ST Segment Resolution in STEMI Patients Treated
Withdrawn
- STEMI - ST Elevation Myocardial Infarction
- Thrombolytic
- +4 more
- (no location specified)
Feb 1, 2023
ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus Trial in Chang chun (Rivaroxaban 15 MG [Xarelto])
Recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Left Ventricular Thrombus
- Rivaroxaban 15 MG [Xarelto]
-
Chang chun, Jilin, ChinaJilin university
May 28, 2023
ST Elevation Myocardial Infarction Trial in Bucheon (Repatha®)
Recruiting
- ST Elevation Myocardial Infarction
-
Bucheon, Korea, Republic ofSejong General Hospital
Oct 10, 2023
Myocardial Infarction, Reperfusion Injury, Myocardial Trial in Uxbridge (Transcoronary cooling and dilution, Standard of care)
Recruiting
- Myocardial Infarction
- Reperfusion Injury, Myocardial
- Transcoronary cooling and dilution
- Standard of care
-
Uxbridge, United KingdomHarefield Hospital
Nov 7, 2023
STEMI - ST Elevation Myocardial Infarction Trial
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- (no location specified)
Dec 24, 2022
STEMI Trial in Kuala Lumpur (Oral Colchicine 0.6 mg, Oral Pyridoxine 10 mg)
Recruiting
- STEMI
- Oral Colchicine 0.6 mg
- Oral Pyridoxine 10 mg
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaNationa University of Malaysia
Aug 27, 2023
Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction Trial in Tehran (Rivaroxaban 15 MG, Warfarin)
Recruiting
- Left Ventricular Thrombus
- ST Segment Elevation Myocardial Infarction
- Rivaroxaban 15 MG
- Warfarin
-
Tehran, Iran, Islamic Republic of
- +1 more
Jan 21, 2023
ST Elevation Myocardial Infarction Trial (PCI)
Not yet recruiting
- ST Elevation Myocardial Infarction
- PCI
- (no location specified)
Jul 22, 2023
Cardiovascular Diseases Trial in Chongqing (ST-segment resolution <40.15%)
Completed
- Cardiovascular Diseases
- ST-segment resolution <40.15%
-
Chongqing, Chongqing, ChinaThe first affiliated hospital of Chongqing medical university
Oct 7, 2020
Acute Coronary Syndrome, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention Trial in Beijing (Intrathrombus
Recruiting
- Acute Coronary Syndrome
- +2 more
- Intrathrombus Thrombolysis During Primary PCI
- Aspiration Thrombectomy During Primary PCI
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Sep 22, 2022
Intravascular ULTRAsound-Guided PCI in ST-Elevation Myocardial
Not yet recruiting
- STEMI
- +2 more
- IVUS imaging for primary PCI guidance
- (no location specified)
Jul 25, 2023
ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention Trial in Shanghai (Nicorandil, Placebo)
Recruiting
- ST Elevation Myocardial Infarction
- Percutaneous Coronary Intervention
- Nicorandil
- Placebo
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jul 26, 2022
Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina Trial
Not yet recruiting
- Non ST Segment Elevation Acute Coronary Syndrome
- +2 more
- De-escalation to ticagrelor 60 mg at day 30
- +3 more
-
Bydgoszcz, Kujawsko-pomorskie, PolandDepartment of Cardiology, Dr. A. Jurasz University Hospital, Col
Mar 9, 2023
SuperSaturated Oxygen (SSO2) Therapy Clinical Utility
Not yet recruiting
- Acute ST Segment Elevation Myocardial Infarction
- (no location specified)
Jul 14, 2023
ST Elevation Myocardial Infarction Trial in Netherlands (Ticagrelor, Aspirin)
Recruiting
- ST Elevation Myocardial Infarction
-
Alkmaar, Netherlands
- +4 more
Aug 3, 2023
Non-ST Elevation Myocardial Infarction (NSTEMI) Trial in Lugano (Cardiovascular Magnetic Resonance)
Recruiting
- Non-ST Elevation Myocardial Infarction (NSTEMI)
- Cardiovascular Magnetic Resonance
-
Lugano, Ticino, SwitzerlandIstituto Cardiocentro Ticino
Feb 20, 2023
Safety Issues, Effect of Drug Trial in Yogyakarta, Jakarta, Bali (Enoxaparin sodium injection)
Recruiting
- Safety Issues
- Effect of Drug
- Enoxaparin sodium injection
-
Yogyakarta, D.I.Yogyakarta, Indonesia
- +2 more
Oct 29, 2023
Safety Issues Trial in Kaohsiung city (OmniMSC-AMI)
Not yet recruiting
- Safety Issues
- OmniMSC-AMI
-
Kaohsiung city, TaiwanKaohsiung Chang Gung Memorial Hospital
Feb 9, 2023
Myocardial Infarction, ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction Trial in London
Recruiting
- Myocardial Infarction
- +2 more
-
London, United Kingdom
- +1 more
Sep 8, 2023
ST-segment Elevation Myocardial Infarction (STEMI) Trial (No aspirin (Prasugurel monotherapy), 12-month DAPT)
Not yet recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- No aspirin (Prasugurel monotherapy)
- 12-month DAPT
- (no location specified)
Feb 1, 2023
Myonectin Concentration and Course of ST-segment Elevation
Recruiting
- ST Elevation Myocardial Infarction
-
Elblag, Warminsko-mazurskie, PolandVoivodeship Hospital in Elblag
Jan 17, 2023
ST Segment Elevation Myocardial Infarction
Completed
- Factor XIII Deficiency
- +3 more
-
Padua, PD, ItalyUniversity of Padua, Cardiology Clinic
May 18, 2022
Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Combined risk score, Usual care, point-of-care
Not yet recruiting
- Acute Coronary Syndrome
- Non ST Segment Elevation Acute Coronary Syndrome
- Combined risk score
- +2 more
- (no location specified)
Sep 18, 2023
ST Elevation Myocardial Infarction Trial in Taichung (Allogeneic umbilical cord mesenchymal stem cells, Control group)
Recruiting
- ST Elevation Myocardial Infarction
- Allogeneic umbilical cord mesenchymal stem cells
- Control group
-
Taichung, TaiwanChina Medical University Hospital
Nov 17, 2023